RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MONTECUCCO C
Collezione ASL Vercelli

Items : 3

Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry. in Frontiers in pharmacology / Front Pharmacol. 2025 Feb 19;16:1462254. doi: 10.3389/fphar.2025.1462254. eCollection 2025.

2025
ASL Vercelli

Vitale A; Caggiano V; Leone F; Hinojosa-Azaola A; Martín-Nares E; Guaracha-Basañez GA; Torres-Ruiz J; Kawakami-Campos PA; Hissaria P; Callisto A; Beecher M; Dagna L; Campochiaro C; Tomelleri A; Frassi M; Franceschini F; Crisafulli F; Hernández-Rodríguez J; Gómez-Caverzaschi V; Araújo O; Sfriso P; Bindoli S; Baggio C; Sota J; Tufan A; Kucuk H; Piga M; Cauli A; D'Agostino MA; et alii...

Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network. in Frontiers in pharmacology / Front Pharmacol. 2025 Mar 7;16:1539756. doi: 10.3389/fphar.2025.1539756. eCollection 2025.

2025
ASL Vercelli

Vitale A; Leone F; Caggiano V; Hinojosa-Azaola A; Martín-Nares E; Guaracha-Basañez GA; Torres-Ruiz J; Ayumi Kawakami-Campos P; Hissaria P; Callisto A; Beecher M; Dagna L; Tomelleri A; Campochiaro C; Frassi M; Crisafulli F; Franceschini F; Hernández-Rodríguez J; Gómez-Caverzaschi V; Araújo O; Sfriso P; Bindoli S; Baggio C; Sbalchiero J; Sota J; Tufan A; Vasi I; Piga M; Cauli A; et alii...

Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission. in Autoimmunity reviews / Autoimmun Rev. 2023 Dec;22(12):103400. doi: 10.1016/j.autrev.2023.103400. Epub 2023 Jul 22.

2023
ASL Città di Torino
AOU Città della Salute di Torino
ASL Vercelli

Cantarini L; Ruscitti P; Priori R; Pappagallo G; Pistone G; Leccese P; Montecucco C; Iannone F; Govoni M; Dagna L; Caporali R; Ciccia F; Colafrancesco S; Sfriso P; Giacomelli R;